PlainPill

Indole-3-Carbinol

The short answer. There isn't much data on Indole-3-Carbinol yet — 10 mentions, 5 with a clear outcome — so treat these numbers as anecdotal. It is most often used for hormones: 100% of 5 reports say that improved. It is well studied — 6 meta-analyses on PubMed.

What users report
80%helped5 reports · few reports
4 helped0 mixed1 didn't help

From 10 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
6
meta-analyses
14
RCTs
1,199
papers

What Indole-3-Carbinol does, according to users

Of the people who reported each effect, the share who said it got better.

betterno changeworse

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 6 meta-analyses on PubMed ↗ · 14 randomized trials ↗

Cochrane Database Syst Rev · 2016 · Meta-analysis / systematic review
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia

Conclusion: Topical treatment (imiquimod or cidofovir) may effectively treat about half of uVIN cases after a 16-week course of treatment, but the evidence on whether this effect is sustained is limited. Factors predicting response to treatment are not clear, but small lesions may be more likely to respond. The relative risk of progression to vulval cancer is uncertain. However, imiquimod and cidofovir appear to be relatively well tolerated and may be favoured by some women over primary surgical treatment.There is currently no evidence on how medical treatment compares with surgical treatment. Women who u

PubMed 26728940 ↗
Cochrane Database Syst Rev · 2011 · Meta-analysis / systematic review
Medical interventions for high grade vulval intraepithelial neoplasia

Conclusion: Imiquimod appears to be effective, but its safety needs further examination. Its use is associated with side effects which are tolerable, but more extensive data on adverse effects are required. Long term follow-up should be mandatory in view of the known progression of high grade VIN to invasive disease. Alternative medical interventions, such as cidofovir, should be explored.

PubMed 21491403 ↗
Cochrane Database Syst Rev · 2015 · Meta-analysis / systematic review
Medical interventions for high-grade vulval intraepithelial neoplasia

Conclusion: Topical imiquimod appears to be a safe and effective treatment for high-grade VIN (uVIN), even though local side-effects may necessitate dose reductions. However, longer term follow-up data are needed to corroborate the limited evidence that response to treatment is sustained, and to assess any effect on progression to vulval cancer. Available evidence suggests that topical cidofovir may be a good alternative to imiquimod; however, more evidence is needed, particularly regarding the relative effectiveness on longer term response and progression. We await the longer-term response data and the r

PubMed 26284429 ↗
Registered clinical trials

13 human trials on ClinicalTrials.gov test Indole-3-Carbinol — 7 completed, 1 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

Approved claims in Canada (Health Canada)
  • Source of (an) antioxidant(s)/Provides (an) antioxidant(s).
  • Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
  • Helps to support/promote healthy estrogen metabolism/balance.

Required cautions: Ask a health care practitioner before use to exclude the diagnosis of a serious cause of hormonal imbalance. Ask a health care practitioner before use if you are taking medications or natural health products. Ask a health care practitioner before use if you are attempting to conceive.

Health Canada monograph: Indole-3-carbinol ↗

Health claims in the EU (European Commission)

No health claim for Indole-3-Carbinol is authorised in the EU.

2 proposed claims were rejected, usually because EFSA found the evidence insufficient (example ↗).

US government research funding (NIH)

NIH has funded 14 research projects with Indole-3-Carbinol in the title, $6,609,043 in total (1992–2019). NIH RePORTER ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

0.2 gdaily
200mgas reported

Reported side effects

How often each side effect came up across all reports.

No side effects reported so far.

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“Indole-3-carbinol is good for reducing estrogen metabolism, which I at least gives you a similar feeling to increased test, if not actually upping it.”
HelpedRead the discussion ↗
“I personally like eating a ton of brocolli/cabbage (for the Indole-3-carbinol content)...with the above two in my diet at least twice a day the puffiness is greatly reduced”
HelpedRead the discussion ↗
“I use resveratrol, but only because I work for a supplement company...Other than that I just eat lots of broccoli for the I3C”
HelpedRead the discussion ↗
Top discussions (5)

Other options for hormones

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate